John C. van Swieten

62.3k citations

268 papers · 23.7k indexed · 6 hit papers · h-index 64

Neurology top 0.02%
- Amyotrophic Lateral Sclerosis Research 75
- Parkinson's Disease Mechanisms and Treatments 46
- Neurological diseases and metabolism 35
Neurology top 0.05%
- Amyotrophic Lateral Sclerosis Research 75
- Parkinson's Disease Mechanisms and Treatments 46
- Neurological diseases and metabolism 35
Psychiatry and Mental health top 0.1%
- Dementia and Cognitive Impairment Research 83
Physiology top 0.1%
- Alzheimer's disease research and treatments 115
Rehabilitation top 0.1%
Molecular Biology
- Prion Diseases and Protein Misfolding 29
Radiology, Nuclear Medicine and Imaging
- Advanced Neuroimaging Techniques and Applications 24
Cellular and Molecular Neuroscience
- Genetic Neurodegenerative Diseases 17

Co-authors: J. van Gijn Peter J. Koudstaal Marieke C. Visser H J Schouten Peter Heutink Monique M.B. Breteler Albert Hofman Lize C. Jiskoot
Cited by: Neurology Psychiatry and Mental health
Journals: Science (1 paper)The Lancet (1 paper)Nature Communications (1 paper)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

John C. van Swieten

260 papers receiving 23.3k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2017 Dementia and Geriatric Cognitive Disorders
2005 Annals of Neurology
2004 PubMed
2003 Science
1994 Neurology
1988 Stroke

Peers

Countries citing papers authored by John C. van Swieten

Since Specialization

Citations

This map shows the geographic impact of John C. van Swieten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. van Swieten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. van Swieten more than expected).

Fields of papers citing papers by John C. van Swieten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. van Swieten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. van Swieten. The network helps show where John C. van Swieten may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John C. van Swieten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John C. van Swieten Line = papers co-authored together John C. van Swieten links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Allosteric modulation of protein kinase A in individuals affected by NLPD ‐ PKA , a neurodegenerative disease in which the PRKAR1B L50R variant is expressed FEBS Journal ·Tal Benjamin‐Zukerman,Valeria Pane,Rania Safadi‐Safa,Meir Solomon,Varda Lev‐Ram,Mohammad Aboraya,Anwar Dakwar,Daniela Bertinetti,Andrew J. Hoy,Merel O. Mol,John C. van Swieten,Rodrigo A. Maillard,Friedrich W. Herberg,Ronit Ilouz	2025	0
2	Investigating the role of neuroinflammation and brain clearance in frontotemporal lobar degeneration using 7T MRI and fluid biomarkers: protocol for a cross-sectional study in a tertiary care setting BMJ Open ·Fieke Prinse,Louise van der Weerd,John C. van Swieten,Itamar Ronen,Harro Seelaar,Lydiane Hirschler,Chloé Najac,Elise G.P. Dopper	2025	2
3	Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia Molecular Neurodegeneration ·Yanaika S. Hok‐A‐Hin,Lisa Vermunt,Carel F.W. Peeters,Emma L. van der Ende,Sterre C.M. de Boer,Lieke Meeter,Julie de Houwer,Harro Seelaar,John C. van Swieten,William T. Hu,Alberto Lleó,Daniel Alcolea,Sebastiaan Engelborghs,Anne Sieben,Alice Chen‐Plotkin,David J. Irwin,Wiesje M. van der Flier,Yolande A.L. Pijnenburg,Charlotte E. Teunissen,Marta del Campo	2025	1
4	Two novel variants in GRN: the relevance of CNV analysis and genetic screening in FTLD patients with a negative family history Journal of Neurology ·Julie F. H. De Houwer,Elise G.P. Dopper,Ana Rajicic,Renee van Buuren,Marina Arcaro,Daniela Galimberti,Guido J. Breedveld,Martina Wilke,Rick van Minkelen,Lize C. Jiskoot,John C. van Swieten,Laura Donker Kaat,Harro Seelaar	2024	1
5	The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration Science Translational Medicine ·Jiechao Zhou,Sarah D. Wade,David Graykowski,Mei-Fang Xiao,Binhui Zhao,Lucia Giannini,Jesse E. Hanson,John C. van Swieten,Morgan Sheng,Paul Worley,Borislav Dejanovic	2023	69
6	Antibodies Associated With Autoimmune Encephalitis in Patients With Presumed Neurodegenerative Dementia Neurology Neuroimmunology & Neuroinflammation ·Anna E.M. Bastiaansen,Robin W. van Steenhoven,Esmee S. te Vaarwerk,Wiesje M. van der Flier,Charlotte E. Teunissen,Esther de Graaff,Mariska M.P. Nagtzaam,Manuela Paunovic,Suzanne C. Franken,Marco W.J. Schreurs,Frank Leypoldt,Peter A.E. Sillevis Smitt,Juna M. de Vries,Harro Seelaar,John C. van Swieten,Frank Jan de Jong,Yolande A.L. Pijnenburg,Maarten J. Titulaer	2023	17
7	CSF proteomics in autosomal dominant Alzheimer’s disease highlights parallels with sporadic disease Brain ·Emma L. van der Ende,Sjors G. J. G. In ‘t Veld,Iris Hanskamp,Sven J. van der Lee,Janna I.R. Dijkstra,Yanaika S. Hok‐A‐Hin,Elena R. Blujdea,John C. van Swieten,David J. Irwin,Alice Chen‐Plotkin,William T. Hu,Afina W. Lemstra,Yolande A.L. Pijnenburg,Wiesje M. van der Flier,Marta del Campo,Charlotte E. Teunissen,Lisa Vermunt	2023	27
8	Frontotemporal lobar degeneration Nature Reviews Disease Primers ·Murray Grossman,William W. Seeley,Adam L. Boxer,Argye E. Hillis,David S. Knopman,Peter A. Ljubenov,Bruce L. Miller,Olivier Piguet,Rosa Rademakers,Jennifer L. Whitwell,Henrik Zetterberg,John C. van Swieten	2023	70
9	Neurovascular dysfunction in GRN-associated frontotemporal dementia identified by single-nucleus RNA sequencing of human cerebral cortex Nature Neuroscience ·Emma Gerrits,Lucia Giannini,Nieske Brouwer,Shamiram Melhem,Danielle Seilhean,Isabelle Le Ber,(unknown),Alwin Kamermans,Gijs Kooij,Helga E. de Vries,Erik Boddeke,Harro Seelaar,John C. van Swieten,Bart J. L. Eggen	2022	43
10	The severity of behavioural symptoms in FTD is linked to the loss of GABRQ‐expressing VENs and pyramidal neurons Neuropathology and Applied Neurobiology ·Priya Gami‐Patel,Marta Scarioni,Femke H. Bouwman,Baayla D.C. Boon,John C. van Swieten,Netherlands Brain Bank,Annemieke J.M. Rozemüller,August B. Smit,Yolande A.L. Pijnenburg,Jeroen J.M. Hoozemans,Anke A. Dijkstra	2022	9
11	Apolipoprotein L1 is increased in frontotemporal lobar degeneration post-mortem brain but not in ante-mortem cerebrospinal fluid Neurobiology of Disease ·Yanaika S. Hok‐A‐Hin,Anke A. Dijkstra,Alberto Rábano,Jeroen J.M. Hoozemans,Lucía Castillo,Harro Seelaar,John C. van Swieten,Yolande A.L. Pijnenburg,Charlotte E. Teunissen,Marta del Campo	2022	3
12	SomaticTARDBPvariants as a cause of semantic dementia Brain ·Jeroen van Rooij,Merel O. Mol,Shamiram Melhem,Pelle van der Wal,Pascal Arp,Francesca Paron,Laura Donker Kaat,Harro Seelaar,(unknown),Suzanne S. M. Miedema,Takuya Oshima,Bart J. L. Eggen,André G. Uitterlinden,Joyce B. J. van Meurs,Ronald E. van Kesteren,August B. Smit,Emanuele Buratti,John C. van Swieten	2020	17
13	Differences in Discriminability and Response Bias on Rey Auditory Verbal Learning Test Delayed Recognition in Behavioral Variant Frontotemporal Dementia and Alzheimer’s Disease Journal of the International Neuropsychological Society ·Esther van den Berg,Jackie M. Poos,Lize C. Jiskoot,L.M. Heijnen,Sanne Franzen,Rebecca M. E. Steketee,Rozanna Meijboom,Frank Jan de Jong,Harro Seelaar,John C. van Swieten,Janne M. Papma	2020	8
14	Review: Fluid biomarkers for frontotemporal dementias Neuropathology and Applied Neurobiology ·Henrik Zetterberg,John C. van Swieten,Adam L. Boxer,Jonathan D. Rohrer	2018	33
15	Hippocampal transcriptome profiling combined with protein-protein interaction analysis elucidates Alzheimer's disease pathways and genes Neurobiology of Aging ·Jeroen van Rooij,Lieke Meeter,Shami Melhem,Diana A.T. Nijholt,Tsz Hang Wong,Annemieke J.M. Rozemüller,André G. Uitterlinden,Joyce B. J. van Meurs,John C. van Swieten	2018	32
16	EIF2AK3 variants in Dutch patients with Alzheimer's disease Neurobiology of Aging ·Tsz Hang Wong,Sven J. van der Lee,Jeroen van Rooij,Lieke Meeter,Petra Frick,Shamiram Melhem,Harro Seelaar,M. Arfan Ikram,Annemieke J.M. Rozemüller,Henne Holstege,Marc Hulsman,André G. Uitterlinden,Manuela Neumann,Jeroen J.M. Hoozemans,Cornelia M. van Duijn,Rosa Rademakers,John C. van Swieten	2018	9
17	¹⁸ F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers Brain ·Ruben Smith,Andreas Puschmann,Michael Schöll,Tomas Ohlsson,John C. van Swieten,Michael Honer,Elisabet Englund,Oskar Hansson	2016	130
18	A novel CCM2 variant in a family with non‐progressive cognitive complaints and cerebral microbleeds American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Petra E. Cohn‐Hokke,Henne Holstege,Marjan M. Weiss,Wiesje M. van der Flier,Frederik Barkhof,Erik A. Sistermans,Yolande A.L. Pijnenburg,John C. van Swieten,Hanne Meijers‐Heijboer,Philip Scheltens	2016	4
19	Familial aggregation of parkinsonism in progressive supranuclear palsy Neurology ·Laura Donker Kaat,Agnita J.W. Boon,Asma Azmani,Wouter Kamphorst,Monique M.B. Breteler,Burcu Anar,Peter Heutink,John C. van Swieten	2009	42
20	New developments in frontotemporal dementia and parkinsonism linked to chromosome 17 Current Opinion in Neurology ·Sonia M. Rosso,John C. van Swieten	2002	34

About John C. van Swieten

John C. van Swieten is a scholar working on Neurology, Psychiatry and Mental health and Neurology, having authored 268 papers that have together received 23.7k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (115 papers), Dementia and Cognitive Impairment Research (83 papers), Amyotrophic Lateral Sclerosis Research (75 papers), Parkinson's Disease Mechanisms and Treatments (46 papers), Neurological diseases and metabolism (35 papers), Prion Diseases and Protein Misfolding (29 papers), Advanced Neuroimaging Techniques and Applications (24 papers) and Genetic Neurodegenerative Diseases (17 papers). The work is most often cited by research in Neurology (10.0k citations), Neurology (4.2k citations) and Psychiatry and Mental health (4.9k citations). John C. van Swieten has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include J. van Gijn, Peter J. Koudstaal, Marieke C. Visser, H J Schouten, Peter Heutink, Monique M.B. Breteler, Albert Hofman, Lize C. Jiskoot, Cornelia M. van Duijn and Annemieke Ruitenberg. Their work appears in journals such as Science, The Lancet and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact